Project 4: Genetic drivers of infection by the RNA virus Lassa Virus and implications for human disease

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 1P20GM156712-01

Grant search

Key facts

  • Disease

    Lassa Haemorrhagic Fever
  • Start & end year

    2025.0
    2030.0
  • Known Financial Commitments (USD)

    $290,851
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    ASSISTANT PROFESSOR Katherine Siddle
  • Research Location

    United States of America
  • Lead Research Institution

    BROWN UNIVERSITY
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

PROJECT 4 PROJECT SUMMARY Lassa virus-the etiological agent of Lassa Fever, a severe hemorrhagic fever with high mortality rates-is an RNA virus endemic to a large region of West Africa. Lassa virus (LASV) is genetically diverse, and current viral lineages circulating in Nigeria and the Mano River Union are estimated to have diverged from each other over 1000 years ago. Viral genetic diversity is suspected to play a role in variability in disease severity observed in some clinical and animal studies. However, to what extent viral genetics plays a role in this phenotype and which loci are most important for disease outcomes remains unknown. To shed light on the role of viral genetic variation on LASV infection and disease, this project will i) interrogate genome-wide inter-lineage variability in infection and replication, and ii) systematically map the impact on viral entry of all variable sites in the LASV glycoprotein, the key gene involved in viral entry, and determine their likely impact on RNA structure and association with sequence conservation. The results of this study will provide novel insights into LASV functional genomics and offer indications for future clinical studies to rigorously investigate variability in disease outcome.